Transition of children with inflammatory bowel disease: big task, little evidence

Wael El-Matary1

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Stollery Children's Hospital, Faculty of Medicine, University of Alberta, Alberta T6G 2J3, Canada. elmatary@ualberta.ca

Insights

Transitioning pediatric patients with inflammatory bowel disease (IBD) to adult care is crucial but lacks research. This review examines the complexities and evidence surrounding IBD care transition.

Area of Science:

  • Pediatric Gastroenterology
  • Healthcare Transition Research
  • Inflammatory Bowel Disease (IBD) Management

Background:

  • Adolescents and young adults with chronic conditions require a planned transition from pediatric to adult healthcare systems.
  • Effective transition of care is vital for long-term health outcomes but is often complex and poorly researched.
  • Specific challenges exist in the transition of pediatric inflammatory bowel disease (IBD) patients due to a lack of dedicated research and standardized protocols.

Purpose of the Study:

  • To review the available evidence on the transition of care for pediatric patients with inflammatory bowel disease (IBD).
  • To highlight the complexities and inconsistencies in current transition practices for IBD patients.
  • To underscore the need for further research and standardized approaches in IBD care transition.

Main Methods:

  • Literature review of existing studies and evidence on healthcare transition for pediatric IBD patients.
  • Analysis of variations in transition age and practices across different healthcare settings and regions.
  • Discussion of factors influencing transition decisions beyond patient welfare.

Main Results:

  • There is a significant deficiency in research specifically addressing the transition of pediatric IBD patients to adult care.
  • Practices and age of transition vary considerably among different centers, countries, and even within regions.
  • Factors such as local politics can influence transition timing, often overshadowing patient-centered considerations.

Conclusions:

  • The transition of care for pediatric IBD patients is a critical but under-researched area requiring urgent attention.
  • Standardized, evidence-based guidelines are needed to ensure a smooth and effective transition process for these individuals.
  • Further research is essential to address the current gaps in knowledge and improve transition outcomes for young adults with IBD.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...